Affiliation:
1. QPS Netherlands, Bioanalysis & Drug Metabolism, Petrus Campersingel 123, 9713 AG Groningen, The Netherlands
Abstract
It is commonly acknowledged that random and systematic analytical errors contribute to poor data quality, and moreover, to imprecise and inaccurate pharmacokinetic parameters. To investigate the random errors in GLP bioanalysis, common ground has been found in today’s bioanalysis to assess the reproducibility of the method by reanalyzing part of the incurred samples. The undesired systematic errors in bioanalysis affecting the trueness of the method and leading to inaccurate data remain relatively unattended so far. In order to obtain both precise and accurate data it is suggested in this paper to apply standard addition experiments to calculate the relative systematic errors as an estimate for the incurred sample accuracy. This approach, which can be seen as an important extension to current guidelines in GLP bioanalysis, is illustrated by assessing the accuracy of the bioanalytical results for a bioequivalence study for alendronate.
Subject
Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry
Reference16 articles.
1. WielingJ, Oosterhuis B, Jonkman JHG. Consequences of variation of bioanalytical methods on the estimation of pharmacokinetic parameters: simulation and laboratory experience.In:Proceedings of Bio-International ‘94. Midha KK, Blume H (Eds). Medpharm Scientific Publishers, Stuttgart, Germany,371–384 (1995).
2. Analysis of recent pharmaceutical regulatory documents on analytical method validation
3. International Conference on Harmonization (ICH) of technical requirements for registration of pharmaceuticals for human use. Topic Q2(R1): validation of analytical procedures: text and methodology (2005).
4. Harmonization of strategies for the validation of quantitative analytical procedures
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献